Detalles de la búsqueda
1.
HIV skews the SARS-CoV-2 B cell response towards an extrafollicular maturation pathway.
Elife
; 112022 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36300787
2.
Development of highly potent neutralising nanobodies against multiple SARS-CoV-2 variants including the variant of concern B.1.351
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-439360
3.
SARS-CoV-2 cell-to-cell spread occurs rapidly and is insensitive to antibody neutralization
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-446516
4.
HIV skews the SARS-CoV-2 B cell response toward an extrafollicular maturation pathway
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-496062
5.
Escape of SARS-CoV-2 501Y.V2 variants from neutralization by convalescent plasma
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21250224
6.
Beta infection combined with Pfizer BNT162b2 vaccination leads to broadened neutralizing immunity against Omicron
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22273711
7.
Divergence of delta and beta variants and SARS-CoV-2 evolved in prolonged infection into distinct serological phenotypes
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21263564
8.
Efficacy of the AZD1222 (ChAdOx1 nCoV-19) COVID-19 Vaccine Against SARS-CoV-2 Variants of Concern
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22277743
9.
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21267417
10.
Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21251247
Resultados
1 -
10
de 10
1
Próxima >
>>